Translate this page into:
Clinical and Laboratory Investigations
PMID: 28176720
Oxytetracycline in Pyoderma
AK Sharma, R Gupta, Uma Saxena, RK Jain
,
Correspondence Address:
Correspondence Address:
| How to cite this article: Sharma A K, Gupta R, Saxena U, Jain R K. Oxytetracycline in Pyoderma. Indian J Dermatol Venereol Leprol 1983;49:118-121 |
Copyright: (C)1983 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
One hundred patients with moderate to severe pyoderma were treated with oral oxytetracycline. The most common organism isolated were coagulase positive Staph pyogenes and Str betahemolyticus. Of 100 patients; 87 showed a successful therapeutic response. The predictive value of in vitro test for bacterial susceptibility to oxytetracycline (30 mcg disc) was 88% for "sensitive" reports but 17% for "resistant" reports.Judged by clinical response the incidence of false sensitive reports was 12% (9/87) but that of false resistant reports was 83 (22/26).Fulltext Views
1,339
PDF downloads
291
